The NRAS mutation is found in several cancers such as melanoma (13 ~ 25%), colorectal cancer (1 ~ 6%), lung cancer (1%), thyroid cancer (7%) and hepatocellular carcinoma (10%). It is known that the response to colorectal cancer drug such as Erbitux and Cetuximab decreased and the prognosis of the patient with metastatic colorectal cancer is poor if the patient has NRAS mutation.
PNAClamp™ Mutation Detection Kit NRAS
For detection of NRAS mutations in tissue biopsies
Cat. No. PNAC-1101
Other products
ExcelRT™ Reverse Transcriptase, (200 U/μl, 20000 U) – RP1000
ExcelRT ™ reverse transcriptase is a recombinant reverse transcriptase from...
ExcelBand 100 bp+3K DNA Ladder, 500 μl – DM2300
The DM2300 ExcelBand™ 100 bp+3K DNA Ladder kit is a...
PCR Strip tubes
PCR Strip tubes
PANAMutyper™ R KRAS
To detect KRAS mutations and determine their response to various...